Latest filing published 06 Apr 2026 for Beam Therapeutics Inc., €126k.
Christine Bellon appears in our data through filings on Beam Therapeutics Inc. shares, published by SEC (Form 4). In total, 28 filings cover trades dated from 30 March 2023 to 1 April 2026.
The open-market record consists of 18 sales worth €1.7M, with no purchase. Outside the open market, there are 4 share grants and 6 option exercises. In 2026 alone, the filings show no purchases and 6 sales.
Most recently, on 6 April 2026, the filings show an open-market sale worth €126k in Beam Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations